You have 9 free searches left this month | for more free features.

albumin bound paclitaxel

Showing 1 - 25 of 4,750

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Locally Advanced Cervical Cancer Trial in Xi'an (Zimberelimab, Albumin-bound Paclitaxel, Cisplatin)

Recruiting
  • Locally Advanced Cervical Cancer
  • Xi'an, Shaanxi, China
    Hongxi Zhao
Sep 20, 2023

PDAC - Pancreatic Ductal Adenocarcinoma Trial (Combination of sitagliptin+ gemcitabine + nab-paclitaxel)

Not yet recruiting
  • PDAC - Pancreatic Ductal Adenocarcinoma
  • Combination of sitagliptin+ gemcitabine + nab-paclitaxel
  • (no location specified)
Jul 9, 2023

Advanced Non-squamous Non-small-cell Lung Cancer, Recurrent Non-Squamous NSCLC, Metastatic Non-squamous Non Small Cell Lung

Not yet recruiting
  • Advanced Non-squamous Non-small-cell Lung Cancer
  • +2 more
  • Beijing, Beijing, China
    Peking University First Hospital Ethics Committee
Sep 10, 2023

Pancreatic Cancer Trial in Tianjin (surufatinib + gemcitabine + nab-paclitaxel)

Recruiting
  • Pancreatic Cancer
  • surufatinib + gemcitabine + nab-paclitaxel
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Jun 15, 2023

HNSCC, Oral Cancer, PD-1 Trial in Guangzhou (Perbolizumab+Carboplatin+albumin-bound paclitaxel:4 courses,

Recruiting
  • HNSCC
  • +2 more
  • Perbolizumab+Carboplatin+albumin-bound paclitaxel:4 courses
  • Perbolizumab+Carboplatin+albumin-bound paclitaxel:2 courses
  • Guangzhou, Guangdong, China
    Sun yat-sen memorial hospital
Aug 6, 2023

Gastric Cancer, GastroEsophageal Cancer Trial in Wuhan (Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor), Albumin-bound

Active, not recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Albumin-bound Paclitaxel Plus SHR-1210 (PD-1 inhibitor)
  • Albumin-bound Paclitaxel
  • Wuhan, Hubei, China
    Tongji hospital of Tongji Medical College, Huazhong University o
Jan 21, 2023

Locally Advanced Pancreatic Cancer Trial in Shanghai (Tumor treating fields combined with Gemcitabine HCl and albumin binding

Not yet recruiting
  • Locally Advanced Pancreatic Cancer
  • Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
  • Gemcitabine hydrochloride and albumin binding paclitaxel
  • Shanghai, Shanghai, China
    Huashan Hospital Affiliated to Fudan University
Dec 8, 2022

Early Breast Cancer Trial in Zhengzhou (monosialic gangliosides, Placebo)

Withdrawn
  • Early Breast Cancer
  • monosialic gangliosides
  • Placebo
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Nov 19, 2022

NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

Recruiting
  • Non-small Cell Lung Cancer
  • Hypofractionated radiotherapy
  • +4 more
  • Guangzhou, Guangdong, China
    Sun yat-sen university cancer center
Nov 14, 2023

Breast Cancer Trial in Chengdu (Pyrotinib combined with albumin-bound paclitaxel and trastuzumab)

Recruiting
  • Breast Cancer
  • Pyrotinib combined with albumin-bound paclitaxel and trastuzumab
  • Chengdu, Chengdu, Sichuan, China, China
    West China Hospital, Sichuan University
Oct 7, 2022

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,

Not yet recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +3 more
  • (no location specified)
Oct 21, 2023

Gastric Adenocarcinoma Trial (cadonilimab combined +paclitaxel (albumin-bound))

Not yet recruiting
  • Gastric Adenocarcinoma
  • cadonilimab combined +paclitaxel (albumin-bound)
  • (no location specified)
Nov 1, 2023

Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma Trial in United States (Laboratory

Active, not recruiting
  • Locally Advanced Breast Carcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +3 more
Jan 31, 2023

Head and Neck Squamous Cell Carcinoma, Oral Cancer Trial in Guangzhou (Tirelizumab ,+Carboplatin+albumin-bound paclitaxel)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Oral Cancer
  • Tirelizumab ,+Carboplatin+albumin-bound paclitaxel
  • Guangzhou, Guangdong, China
    Sun yat-sun memorial hospital
Jul 10, 2023

Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced

Completed
  • Oral Cancer
  • PD-1 inhibitor+carboplatin+albumin-bound paclitaxel
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital
Nov 20, 2023

Angiosarcoma Metastatic Trial in Guangzhou (Abraxane combined with liposomal doxorubicin)

Recruiting
  • Angiosarcoma Metastatic
  • Abraxane combined with liposomal doxorubicin
  • Guangzhou, Guangdong, China
    Xing Zhang
Sep 4, 2022

Cholangiocarcinoma Trial (Carrilizumab, Albumin-bound paclitaxel, Apatinib)

Not yet recruiting
  • Cholangiocarcinoma
  • (no location specified)
Dec 9, 2022

Pancreatic Acinar Cell Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma Trial (Nab paclitaxel,

Not yet recruiting
  • Pancreatic Acinar Cell Carcinoma
  • +6 more
  • Nab paclitaxel
  • +5 more
  • (no location specified)
Oct 30, 2023

Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma

Recruiting
  • Esophageal Squamous Cell Carcinoma
    • Shijiazhuang, Hebei, China
      Department of Thoracic Surgery, Fourth Hospital of Hebei Medical
    Oct 25, 2023

    Second Line Treatment of Gastric Cancer Trial (Camrelizumab, Albumin-Bound Paclitaxel, Irinotecan)

    Not yet recruiting
    • Second Line Treatment of Gastric Cancer
    • (no location specified)
    Dec 20, 2022

    Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)

    Not yet recruiting
    • Advanced Solid Tumor
    • JS015
    • +10 more
    • Shanghai, Shanghai, China
      Shanghai East Hospital
    Nov 17, 2023

    To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast

    Not yet recruiting
    • To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients
    • Monosialotetrahexose ganglioside sodium injection
    • (no location specified)
    Mar 27, 2023

    Recurrent Cervical Cancer Trial in Guangzhou (anti-PD-1+Albumin-Bound Paclitaxel)

    Active, not recruiting
    • Recurrent Cervical Cancer
    • anti-PD-1+Albumin-Bound Paclitaxel
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    May 26, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Withdrawn
    • Anatomic Stage III Breast Cancer AJCC v8
    • +11 more
    • (no location specified)
    Jan 5, 2023

    Ovarian Carcinoma, Platinum-resistant Ovarian Cancer, Recurrent Ovarian Carcinoma Trial in Beijing (Albumin-bound paclitaxel and

    Recruiting
    • Ovarian Carcinoma
    • +6 more
    • Albumin-bound paclitaxel and bevacizumab
    • Beijing, Beijing, China
      Lei Li
    Mar 26, 2022